Our other sites

  • Lyxor ETF

    A pioneer in the ETF market since 2001, Lyxor is one of Europe's largest ETF providers, offering investors more than 220 ways to explore the markets.
  • Lyxor FUNDS

    The Lyxorfunds website allows you to find out more about the Lyxor funds range, its documentation, market and product news.
  • MYLyxor MAP

    MyLyxorMAP website is dedicated to the Lyxor Managed Account Platform (MAP). It offers access to a comprehensive range of managed accounts, providing transparency, liquidity and independent risk management. It may also include other funds managed by Lyxor.
  • Lyxor JAPAN

    Corporate information on Lyxor Asset Management Japan Co. Ltd. , its publicly offered domestic funds, and general information in Japanese about Lyxor.
  • Lyxor IN GERMANY

    Find out more about Lyxor International Asset Management Deutschland, created from the combination of Lyxor’s activities in Germany and the asset management activities division of Commerzbank’s EMC business.

Merger Arbitrage flexes its muscles

Premier paragraphe

Merger Arbitrage has proven to be the most resilient hedge fund strategy throughout the recent market sell-off. The ability of the strategy to protect capital through bad times is something we have underlined in the past and which is bolstered by historical evidence. This is part of the reason why we have been and remain highly constructive on the strategy (at Overweight). Since February 18th, the equity market peak, Merger Arbitrage is down -0.4%, while a 50/50 portfolio of equities and bonds is down -4.6% (based on an MSCI World and Barclays Global Aggregate Bond Index through March 3rd). The strategy was resilient in a context where deal spreads were stable through February 28th, before widening afterward.

Image détail
Merger Arbitrage flexes its muscles

Concurrently, cash levels in portfolios were elevated in early 2020. Seasonal factors, along with the tightness of deal spreads and the completion of several transactions in Q4 all contributed to the elevated cash levels of Merger Arbitrage strategies prior to the selloff. Thus, the recent widening of deal spreads opened opportunities for deploying capital in high conviction deals, i.e. those with an attractive risk/reward profile. Gross spreads on friendly deals have gone from 1% to between 2 and 3% in recent days. Managers started to deploy capital in a number of deals that they have already been invested in, such as Allergan vs. Abbvie and Tiffany vs. LVMH, to name a few. Managers also deployed capital in recently announced transactions such as HP vs. Xerox, E*TRADE vs. Morgan Stanley and UBI vs. Intesa. For some managers, we have seen gross exposures climbing significantly, from 60-70% to 90-100% of net assets.

Outside Merger Arbitrage, it is important to highlight the fact that L/S Credit and EM Macro strategies have also been resilient since Feb 18th (-0.6% and -1%, respectively). Our stance remains at Overweight on both strategies. On a negative note, CTA and Directional L/S Equity strategies underperformed during the same period (-3.6% and -3.2%, respectively). Our stance remains at Neutral on CTA and Underweight on Directional L/S Equity. Yet, within these strategies, dispersion is elevated. The top-performing CTA and Directional L/S within our samples still managed to post positive returns during this troubled period.